2702. Infants Vaccinated with a Fully-Liquid DTaP-IPV-Hib-HepB Vaccine Are Protected During the High-Risk Period for Haemophilus Influenzae Type B Disease

BACKGROUND: DTaP-IPV-Hib-HepB is a fully-liquid, combination vaccine (Vaxelis™) approved for vaccination in infants and toddlers against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b (Hib). Safety and immunogenicity were evaluated in 4 Phase III, random...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilck, Marissa B, Xu, Jin, Stek, Jon E, Lee, Andrew W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809823/
http://dx.doi.org/10.1093/ofid/ofz360.2379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809823/
http://dx.doi.org/10.1093/ofid/ofz360.2379

Ejemplares similares